These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 11378322

  • 1. Successful outcome using quetiapine in a case of treatment-resistant schizophrenia with assaultive behavior.
    Brooks JO.
    Schizophr Res; 2001 May 30; 50(1-2):133-4. PubMed ID: 11378322
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of depressive mood in schizophrenia with the atypical antipsychotic quetiapine.
    Khouzam HR.
    Depress Anxiety; 2000 May 30; 11(2):80-2. PubMed ID: 10812533
    [Abstract] [Full Text] [Related]

  • 3. Attentional improvement following quetiapine fumarate treatment in schizophrenia.
    Sax KW, Strakowski SM, Keck PE.
    Schizophr Res; 1998 Oct 09; 33(3):151-5. PubMed ID: 9789907
    [Abstract] [Full Text] [Related]

  • 4. Adjunctive quetiapine treatment of the polydipsia, intermittent hyponatremia, and psychosis syndrome: a case report.
    Montgomery JH, Tekell JL.
    J Clin Psychiatry; 2003 Mar 09; 64(3):339-41. PubMed ID: 12716283
    [No Abstract] [Full Text] [Related]

  • 5. Antiaggressive action of combined risperidone and quetiapine in a patient with schizophrenia.
    Bozikas VP, Deseri C, Pitsavas S, Karavatos A.
    Can J Psychiatry; 2003 Jul 09; 48(6):426-7. PubMed ID: 12894620
    [No Abstract] [Full Text] [Related]

  • 6. High degree of tolerability for monotherapy with high doses of quetiapine: a case report.
    Bobes J, Garcia-Portilla MP, Saiz PA, Bascaran MT, Bousoño M, Arango C.
    J Clin Psychiatry; 2002 Nov 09; 63(11):1048-9. PubMed ID: 12469690
    [No Abstract] [Full Text] [Related]

  • 7. Quetiapine in the successful combination treatment of an assaultive patient with treatment-resistant schizoaffective disorder.
    Post DE.
    Behav Med; 2007 Nov 09; 33(1):11-4. PubMed ID: 17517541
    [Abstract] [Full Text] [Related]

  • 8. The CATIE schizophrenia effectiveness trial.
    Delisi LE, Nasrallah HA.
    Schizophr Res; 2005 Dec 01; 80(1):v-vi. PubMed ID: 16291292
    [No Abstract] [Full Text] [Related]

  • 9. Quetiapine-associated depression in a patient with schizophrenia.
    Mergui J, Jaworowski S, Lerner V.
    Clin Neuropharmacol; 2005 Dec 01; 28(3):133-5. PubMed ID: 15965312
    [Abstract] [Full Text] [Related]

  • 10. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG.
    Arch Gen Psychiatry; 1997 Jun 01; 54(6):549-57. PubMed ID: 9193196
    [Abstract] [Full Text] [Related]

  • 11. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
    Suzuki T, Uchida H, Watanabe K, Nomura K, Takeuchi H, Tomita M, Tsunoda K, Nio S, Den R, Manki H, Tanabe A, Yagi G, Kashima H.
    Psychopharmacology (Berl); 2007 Dec 01; 195(2):285-95. PubMed ID: 17701027
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial.
    Findling RL, McKenna K, Earley WR, Stankowski J, Pathak S.
    J Child Adolesc Psychopharmacol; 2012 Oct 01; 22(5):327-42. PubMed ID: 23083020
    [Abstract] [Full Text] [Related]

  • 13. A random-assignment, double-blind, clinical trial of once- vs twice-daily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disorder: a pilot study.
    Chengappa KN, Parepally H, Brar JS, Mullen J, Shilling A, Goldstein JM.
    Can J Psychiatry; 2003 Apr 01; 48(3):187-94. PubMed ID: 12728743
    [Abstract] [Full Text] [Related]

  • 14. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
    Riedel M, Spellmann I, Strassnig M, Douhet A, Dehning S, Opgen-Rhein M, Valdevit R, Engel RR, Kleindienst N, Müller N, Möller HJ.
    Eur Arch Psychiatry Clin Neurosci; 2007 Sep 01; 257(6):360-70. PubMed ID: 17629731
    [Abstract] [Full Text] [Related]

  • 15. Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine.
    Kelly DL, Conley RR.
    J Clin Psychiatry; 2005 Jan 01; 66(1):80-4. PubMed ID: 15669892
    [Abstract] [Full Text] [Related]

  • 16. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
    Arvanitis LA, Miller BG.
    Biol Psychiatry; 1997 Aug 15; 42(4):233-46. PubMed ID: 9270900
    [Abstract] [Full Text] [Related]

  • 17. Quetiapine: a well-tolerated and effective atypical antipsychotic.
    Hellewell JS.
    Hosp Med; 2002 Oct 15; 63(10):600-3. PubMed ID: 12422494
    [Abstract] [Full Text] [Related]

  • 18. Quetiapine--efficacy in different domains.
    Sharma T.
    Eur Neuropsychopharmacol; 2001 Oct 15; 11 Suppl 4():S385-90. PubMed ID: 11587885
    [Abstract] [Full Text] [Related]

  • 19. Intranasal quetiapine abuse.
    Pierre JM, Shnayder I, Wirshing DA, Wirshing WC.
    Am J Psychiatry; 2004 Sep 15; 161(9):1718. PubMed ID: 15337673
    [No Abstract] [Full Text] [Related]

  • 20. Quetiapine fumarate for schizophrenia and bipolar disorder in young patients.
    Ribolsi M, Magni V, Rubino IA.
    Drugs Today (Barc); 2010 Aug 15; 46(8):581-7. PubMed ID: 20830318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.